British Shorthair Health Screening Checklist

Breed Identification

British Shorthair Health Screening Checklist

FĒLIS Editorial Feb 2026 18 min read

A British Shorthair that is sick looks pretty much the same as one that isn't. It doesn't cry when it's in pain, it lies around as usual when it's tired, and there's no noticeable change in eating behavior until appetite has dropped quite significantly. How weak are the disease signals in this breed? Many BSH owners recall saying "it was fine just yesterday." It wasn't fine just yesterday. It hadn't been fine for months. The cat simply gave no detectable indication. So health management for British Shorthairs can't rely on observation. It has to rely on screening, and the screening items need to follow the specific genetic weaknesses and physical structure of this breed.

Regarding HCM Genetic Testing, BSH Owners Need to Know Something Most People Don't Know

This goes first because its scope of misleading is the widest.

The commercial HCM genetic tests for cats on the market test two known mutation sites on the MyBPC3 gene. The A31P mutation was discovered and validated in the Maine Coon population. The R820W was discovered and validated in the Ragdoll population. Both sites have solid causal evidence linking them to HCM in Maine Coons and Ragdolls.

The HCM causative mutation site for British Shorthairs has not been identified to this day.

What this means is: a British Shorthair gets an HCM genetic test, the report says "negative," and the only thing that report proves is that this cat does not carry those two specific mutations belonging to Maine Coons and Ragdolls. Regarding the BSH's own HCM genetic risk, this result provides zero information. Negative doesn't mean safe. A positive result would almost never appear anyway, because these two mutations don't belong to the BSH's genetic background in the first place.

This test, for a British Shorthair, is roughly equivalent to taking an exam that answers a question nobody asked.

Breeders marking "both parents HCM genetic test negative" on their sales pages is extremely common. Buyers see that line and naturally form the impression that "this cat's heart has been screened at a genetic level." That impression is wrong, and the consequence is that large numbers of BSH owners relax or completely skip regular cardiac ultrasound screening.

What It Takes for Cardiac Ultrasound to Be Properly Done on a British Shorthair

Since genetic testing is unreliable, cardiac ultrasound becomes the only pathway. BSH HCM is late-onset. The timing of myocardial thickening varies enormously between individuals. Some cats show detectable wall changes at two or three years old, some show nothing at six or seven. So a single normal ultrasound result cannot be treated as case closed. Establish baseline data starting at one year of age, recheck every 12 to 18 months after that, covering at least through age eight.

There is an ultrasound interpretation difficulty directly related to BSH body type.

Standard HCM ultrasound screening measures end-diastolic left ventricular free wall thickness (LVFWd) and interventricular septum thickness (IVSd) on the right parasternal short-axis view using M-mode guidance. Six millimeters is the diagnostic cutoff. British Shorthairs have thick chest walls and more epicardial fat deposition than most breeds. This fat layer looks very similar to myocardial echoes on ultrasound imaging. If the operator doesn't have sufficient BSH ultrasound experience, they may include fat thickness in their myocardial measurement, get an inflated wall thickness reading, and flag a healthy cat as suspected HCM. Errors in the opposite direction also happen: the operator knows BSH cats have more fat, subconsciously measures conservatively, and lets early pathological changes slip through. Being able to cleanly separate the epicardial fat from the myocardial border on a BSH ultrasound image is a threshold of experience. If the option is available, cardiac ultrasound should be handled by a veterinary cardiology specialist.

The LA/Ao ratio (left atrium to aortic root ratio) also needs breed-specific interpretation for BSH. The general standard is below 1.5 as normal. British Shorthairs are large-bodied with a higher baseline blood volume, so healthy individuals may naturally run slightly higher on this ratio than a Siamese of the same weight. The 1.5 to 1.6 range, which would be a notable signal in other breeds, might just be a baseline variance caused by body size in a BSH.

How to tell the difference? Only through longitudinal comparison against this individual cat's own previous values. That is why the complete data from the first ultrasound is so critical. It's the anchor point for every recheck that follows.

NT-proBNP can provide blood-level cardiac monitoring between ultrasound appointments. Keep in mind that BSH cats are heavier, so this marker's baseline will naturally run higher than in lighter breeds. A single mildly elevated reading doesn't say much. Trends across multiple consecutive tests are what matters.

BSH Creatinine Will Lie to You

PKD1 genetic testing has clear efficacy in BSH. It targets the C-to-A mutation on exon 29, a single site shared across all cat breeds, with no breed-applicability issues. Do it once, as early as possible. A negative result reliably excludes autosomal dominant polycystic kidney disease. Completely unlike the HCM genetic testing situation, PKD genetic testing is the most trustworthy item among all BSH hereditary screens.

The part of kidney screening that needs thorough explanation is the long-term monitoring strategy for chronic kidney disease (CKD), because there is an indicator trap tied directly to BSH body type.

Creatinine is a metabolic byproduct of muscle. Individuals with more muscle mass have higher baseline blood creatinine. BSH muscle mass is on the larger end among cat breeds, and healthy British Shorthairs running along the upper edge of the creatinine reference range is normal and doesn't necessarily indicate any kidney problem. Misreading in this direction causes unnecessary worry at most.

The dangerous direction is the reverse. Early CKD is accompanied by muscle wasting. Muscle decreases, creatinine production drops with it, and blood creatinine gets "pulled down." A BSH's creatinine dropping from the upper reference range back to the mid-range, without understanding this mechanism, looks like "the numbers are improving." Kidney function is deteriorating, muscle mass is also shrinking, two lines descending simultaneously, and the creatinine number happens to stabilize in a position that "looks normal." BSH cats have a large muscle baseline, meaning there is more muscle available to lose, so this masking effect operates on a larger scale than in smaller breeds.

SDMA is not affected by muscle mass. It reflects changes in glomerular filtration rate. When a BSH's creatinine looks stable or even declining while SDMA is trending upward year after year, the directional divergence between these two indicators is itself a red flag: kidneys are signaling trouble while creatinine is covering for them.

SDMA has its own interference factors too. BSH cats are not the easiest to draw blood from. They're stocky, their jugular veins sit deeper, restraint during venipuncture is difficult, and the probability of hemolysis is higher than in lean, long-bodied cats. A hemolyzed sample will cause SDMA readings to be falsely elevated. When an abnormally high SDMA result comes back, the first response should not be panic. It should be verifying sample quality, and retesting with a new draw if necessary. Don't skip this step and jump straight to a conclusion.

Don't just check whether an SDMA result is "within range or not." Starting at three years of age, test SDMA and creatinine once a year. Keep the data yourself. Year by year, assemble a trend line. SDMA going from 9 to 11 to 14, each individual reading within the normal reference range, connects into a curve showing continuous decline in filtration rate. In BSH early kidney screening, this habit of longitudinal tracking is far more useful than any single reading of any single indicator.

After age five, add renal ultrasound (reduction in kidney length, cortical thinning, increased cortical echogenicity, loss of corticomedullary differentiation are all early morphological clues of CKD), add urinalysis (urine specific gravity below 1.035 suggests declining concentrating ability, elevated urine protein-to-creatinine ratio suggests glomerular barrier damage). Cross-reference blood, ultrasound, and urine across all three lines.

Blood Typing

Search for BSH health screening content in Chinese, and nine out of ten articles will mention HCM and PKD. Mentions of blood typing are virtually nonexistent. The gap between this level of neglect and the clinical weight of blood type in BSH is abnormally wide.

BSH B-type blood prevalence is among the highest of all cat breeds, roughly 40% to 50% overall, with enormous variation between bloodlines, some traditional European lines exceeding 60%. B-type cats naturally carry high-titer anti-A alloantibodies from birth, no sensitization required. A-type cats also have anti-B antibodies, at very low titers. The risk is completely asymmetric in different directions: a B-type cat mistakenly transfused with A-type blood can develop acute intravascular hemolysis, hemoglobinuria, hypotension, and DIC within minutes. An A-type cat mistakenly transfused with B-type blood usually only experiences mild hemolysis and shortened red blood cell survival.

With the B-type prevalence this high in the BSH population, randomly pulling two British Shorthairs for a transfusion carries a far higher mismatch probability than in most breeds. Emergency transfusions typically happen during car accidents, surgical hemorrhage, and similar scenarios where there's no time for leisurely testing. Whether or not a blood type record already exists in the medical file makes a significant difference to how quickly emergency care can begin. It should be done at the very first clinic visit when the file is established. Rapid blood typing cards give results in minutes and cost next to nothing.

On the breeding side the issue is even more rigid. B-type queen colostrum contains high-concentration anti-A antibodies. After mating with an A-type male (A is dominant over B), A-type kittens nursing within the first 16 to 24 hours after birth, while intestinal permeability has not yet closed, absorb maternal anti-A antibodies directly into the bloodstream, attacking the kitten's own red blood cells. This is neonatal isoerythrolysis (NI). Jaundice, dark urine, progressive anemia, and necrosis of tail tips and toe tips appear on the second to third day after birth. Blood type matching of breeding cats before mating is the only way to prevent NI at the source.

Some breeders have started deliberately favoring A-type individuals in their breeding selections to reduce B-type prevalence and NI incidence in their lines. This approach makes sense in the short term. The tradeoff is that if pushed too far, blood type gene pool homogenization in the breed could have consequences for genetic diversity down the line. No consensus on this balance has been reached in the breeding community.

A Cat That Looks Entirely Like a British Shorthair May Be Carrying the Fold Gene Inside

The outcross cats used to mate with Scottish Folds in fold breeding programs are, in a large proportion, British Shorthairs. Straight-eared offspring from these crosses are visually almost indistinguishable from purebred BSH. Some breeders sell these crossbred kittens as British Shorthairs. The buyer has no idea their cat carries the fold gene (Fd).

The skeletal effects of the fold gene are not bounded by whether the ears are folded or straight. Heterozygous cats (Fdfd) with straight ears can still develop progressive osteophyte formation in distal limb joints, particularly the tarsal and carpal regions, and in the caudal vertebrae. A stiff, short tail that cannot bend normally is the easiest external clue to notice, though many carriers have tails that look completely normal. The problem only shows up on X-ray.

For any BSH with incomplete pedigree documentation or obtained through non-transparent channels, X-ray the distal limbs and full caudal vertebral column around one year of age. Once osteophytes have formed they don't regress. Osteochondrodysplasia is progressive. The value of early detection lies in intervening with management ahead of worsening pain: reducing jumping demands in the home environment, weight control, and discussing pain management protocols with the veterinarian when appropriate.

Hip dysplasia (HD) on its own is also not uncommon in BSH, and early signals are extremely weak. Crouching to hesitate before jumping up, taking a detoured multi-stage route down from heights, occasional simultaneous hind-limb bunny-hopping during a run.

These pain-avoidance behaviors blend too easily with the breed impression that BSH cats "just don't like to move." Any BSH showing these behavioral changes should have a ventrodorsal pelvic X-ray for hip joint assessment.

FORL Typing

BSH short faces, compact jaws, crowded dentition, and higher baseline rates of gingivitis and periodontal disease compared to mesocephalic and dolichocephalic breeds. Routine oral examination catches these surface-level issues.

FORL is a different matter. The lesion begins at the tooth root, driven by abnormal odontoclast activation, eroding dental hard tissue. In the initial stages it is entirely below the gingival line. From the outside, the tooth surface looks perfectly clean and intact. Cats do not refuse food or switch chewing sides because of FORL. They eat normally, behave normally, and experience pain with every bite. Full-mouth dental radiography is the only way to detect FORL.

Popular science articles usually end at "FORL requires extraction." FORL has two types, the treatment approaches are completely different, and mixing them up has concrete consequences.

Type 1: on radiograph, root structure is still present, periodontal ligament space is clearly visible, and there is a definite boundary between root and alveolar bone. Standard treatment is complete extraction including all roots, with post-operative radiograph confirming no retained root fragments.

Type 2: the root is undergoing replacement resorption by osseous tissue. On radiograph, root outline is blurred or absent, fused with surrounding alveolar bone. Attempting to dig out the root in this situation means longer surgery time, longer anesthesia exposure, and risk of iatrogenic alveolar bone fracture, all without necessity, because the body is already replacing these roots with bone. The recommended treatment for Type 2 is crown amputation: removing only the portion of the tooth above the gingival line and allowing the gingiva to cover the cut surface and heal over it.

Type 2 treated as Type 1: excessive surgery, unnecessary bone damage, additional anesthesia risk. Type 1 treated as Type 2: diseased root fragments remain in place, continuing to cause inflammation and pain. Typing on full-mouth dental radiographs requires specialized training, and many general practice veterinarians are not confident in distinguishing the radiographic differences between the two types. When there is uncertainty, referral to a veterinarian with dental experience is appropriate.

Starting at three years of age, full-mouth dental radiography under anesthesia plus periodontal probing every one to two years.

Epiphora

Tear staining and chronic tearing are extremely common in BSH. The volume of dietary adjustment advice generated around this symptom, including switching to hypoallergenic diets, adding fish oil, trying different protein sources, is large enough to constitute its own category. These recommendations assume that epiphora is diet-related, and this assumption does not hold in most BSH cases.

Although BSH cats are not as extremely flat-faced as Persians and Exotic Shorthairs, nasolacrimal duct anatomy is still affected by brachycephalic craniofacial structure. The proportion of individuals with narrowed duct diameter or increased duct curvature is not small. Tear production is normal, drainage is insufficient, fluid overflows from the inner eye corner. A plumbing problem, not a food problem.

The fluorescein passage test provides an initial assessment: fluorescein dye is applied to the cornea, and the nasal opening is checked for detectable fluorescein outflow. If none appears, it indicates nasolacrimal duct narrowing or obstruction. Nasolacrimal duct flushing can then confirm the location. Once a structural cause is confirmed, the management direction becomes simple: regular periocular cleaning to prevent dermatitis from prolonged tear soaking of the skin (porphyrins in tears oxidize to a red-brown stain), and no further investment in diet changes and supplements.

BSH eyes are relatively prominent, the palpebral fissure is wide, the nictitating membrane covers a limited area, and the corneal exposure surface is larger than in breeds where the eye sits deep in the orbit. Traumatic corneal ulceration probability is higher. Multi-cat households are a particular concern. Adding a fluorescein staining corneal examination to the annual checkup is quick, non-invasive, and can detect microscopic epithelial defects invisible to the naked eye.

In Older BSH Cats, Hyperthyroidism and HCM Can Produce the Same Picture on Ultrasound

Hyperthyroidism is common in cats over ten years of age. Hyperthyroidism causes myocardial thickening and increased heart rate, and its ultrasound presentation can look very similar to primary HCM. A BSH that has been on HCM tracking, whose ultrasound at seven or eight years of age suddenly shows thicker ventricular walls than before: whether this change represents HCM progression or thyroid-driven secondary myocardial change can only be determined after checking thyroid function first. Total thyroxine (TT4) should enter the annual routine blood panel starting at age seven.

Sometimes TT4 hovers at the upper end of the reference range without clearly exceeding it, while the cat is already showing weight loss, elevated heart rate, and increased water intake and urine output. Free thyroxine (fT4) can provide additional diagnostic information in these situations. For older BSH cats with an existing HCM monitoring record, TT4 is not a matter of "adding one more test." It directly affects which direction the cardiac ultrasound results get interpreted.

The Metabolic Window After Neutering

BSH activity levels are naturally low, muscle density is high, and basal metabolic rate relative to body weight runs on the lower side. On the same caloric intake, BSH cats enter energy surplus at a much lower threshold than Siamese or Abyssinians. After neutering, sex hormone withdrawal drops basal metabolic rate by roughly another 20% to 30%, while appetite increases simultaneously. If caloric intake is not proactively reduced within the first three to six months after neutering, once the momentum of weight gain establishes itself, the difficulty of reversal increases steeply.

The impact of obesity on BSH extends beyond "heavy body means more joint stress." Increased epicardial fat further interferes with cardiac ultrasound measurement precision (the fat-myocardium echo confusion issue discussed earlier), hip joint wear accelerates, Type 2 diabetes incidence rises markedly in obese BSH individuals, and risk of hepatic lipid accumulation increases. Weight management and screening accuracy are directly connected, not two separate topics.

Weigh monthly. Maintain body condition score (BCS, 1 to 9 scale) at 4 to 5. When palpating the ribs, rib contour should be clearly felt through a thin layer of fat. The abdomen should not have a fat pad hanging down.

How Screening Items Line Up on a Timeline

During the kitten stage, two one-time items: PKD1 genetic testing and blood typing. For individuals with non-transparent pedigree origins, concurrently X-ray distal limbs and caudal vertebrae to screen for fold-gene-associated skeletal changes. Do not do HCM genetic testing. The money spent will not buy information relevant to British Shorthairs.

At one year of age, have a veterinary cardiology specialist perform the first complete cardiac ultrasound. Record LVFWd, IVSd, and LA/Ao in full. First comprehensive blood chemistry panel. Record SDMA, CREA, and BUN baselines. Keep a copy of all data yourself. Don't rely solely on the clinic's record system.

Between two and four years of age, annual checkup including oral examination and corneal fluorescein staining, cardiac ultrasound recheck every 12 to 18 months, annual blood chemistry to continue accumulating kidney indicator data. At three years, first full-mouth dental radiography under anesthesia.

Starting at five, add annual abdominal ultrasound to assess renal morphology, add urinalysis. Cardiac ultrasound frequency shortens to every 12 months.

Starting at seven, add TT4 and NT-proBNP to the annual blood panel. From this age onward, every time kidney indicators come back, lay them alongside the previous years' data and look at the trend, not just whether the numbers are "within range or not." When TT4 runs high at the same time as ventricular wall thickening appears, cardiac and endocrine evaluation need to be conducted jointly.